BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For
more
information on access to our products, please call our
customer service line at 1-800-469-0261.
BDSI works to advance therapies designed to give individuals living with serious and debilitating chronic conditions the opportunity to make the most of their lives.
Discover the BDSI portfolio of productsBioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company committed to finding therapies for serious and debilitating chronic conditions and bringing them to market in the most impactful way possible.
Find out how you can grow with usIn our relentless pursuit of innovative therapies, tools, and technologies, we never lose sight of the human element.
Learn more about our patients-first philosophyAs a patient-centric pharmaceutical company, we are passionate about lifting the burden of serious and debilitating chronic conditions.
Find out how you can put your passion to workSerious and debilitating chronic conditions are complex and often misunderstood, which can leave patients feeling isolated and alone. At BDSI, we believe reaching out and advocating for our patient communities is an important part of driving therapeutic solutions.
Connect with some of our advocacy effortsWith every new product, our mission expands to embrace a new patient population, their caregivers, and family.
Learn how our products may helpBDSI works to advance therapies designed to give individuals living with serious and debilitating chronic conditions the opportunity to make the most of their lives.
Discover the BDSI portfolio of productsBioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company committed to finding therapies for serious and debilitating chronic conditions and bringing them to market in the most impactful way possible.
Find out how you can grow with usIn our relentless pursuit of innovative therapies, tools, and technologies, we never lose sight of the human element.
Learn more about our patients-first philosophyAs a patient-centric pharmaceutical company, we are passionate about lifting the burden of serious and debilitating chronic conditions.
Find out how you can put your passion to workSerious and debilitating chronic conditions are complex and often misunderstood, which can leave patients feeling isolated and alone. At BDSI, we believe reaching out and advocating for our patient communities is an important part of driving therapeutic solutions.
Connect with some of our advocacy effortsWith every new product, our mission expands to embrace a new patient population, their caregivers, and family.
Learn how our products may helpRALEIGH, N.C. , April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021
Read moreTotal Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million Record Level Profitability with Net Income of $25.7 Million , Full-Year EBITDA Margin of 26% and Operating Cash Generation of $25 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today
Read moreRALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full
Read moreStay up to date on the latest news
Get started now